Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Barriers to investigator-initiated deep brain stimulation and device research.
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients.
Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Autologous Haematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Multiple Sclerosis.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
Ampyra for Optic Neuritis in MS
Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
High rates of physician services utilization at least five years before multiple sclerosis diagnosis.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Treatment Update in Multiple Sclerosis.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.

Pages